THC GLOBAL

BUY WEED ONLINE AUSTRALIA

Australian therapeutic cannabis developer THC Global (ASX: THC) has been granted a second manufacturing license, this time for its large Southport facility, making it the largest licensed bio-pharma extraction facility in the Southern Hemisphere.

The license was granted to the company’s wholly-owned subsidiary THC Pharma Pty Ltd by the Australian Office of Drug Control, which approved THC’s first manufacturing license to its subsidiary Canndeo a month ago.

THC GLOBAL AUSTRALIA

THC GLOBAL AUSTRALIA

According to the company, this paves the way for THC Global to be one of the most competitive cannabis producers in the global export market.

This delivers a real clear pathway for the medical cannabis sector here in Australia to become international.

Timeline to production:

·        According to THC, product validation activities are expected to be completed by the end of this year with production anticipated in early 2020.

·        Once we calibrate and validate everything, we’ll have base products available in small scale – a CBD oil for the Australian market straight away, and then our isolates ready for verification.”

·        “Once that’s done, it then leads into the full production and distribution.”

THC has estimated an initial production capacity in excess of 12,000kg of GMP-compliant API isolates for the first year.

·        The company said it also expects to be able to further process these extracts into finished medicines such as oils, tinctures, and capsules.

·        According to THC, the manufacturing license also enables it to expand its product formulation and development activities further to develop new medicinal cannabis products, which are expected to drive medium-term revenue.

 

Copyrighted.com Registered & Protected